Search research articles
Contact Us
Filters
Showing results (21-30 of 44) with videos related to
Page
of 5
Sort By:
Plos Genetics
|
November 21, 2015
Conserved piRNA Expression from a Distinct Set of piRNA Cluster Loci in Eutherian Mammals
Gung-Wei Chirn, Reazur Rahman, Yuliya A Sytnikova, et al.
Genes & Development
|
June 3, 2009
Integration of microRNA miR-122 in hepatic circadian gene expression
David Gatfield, Gwendal Le Martelot, Charles E Vejnar, et al.
Emerging Infectious Diseases
|
May 1, 2009
New respiratory enterovirus and recombinant rhinoviruses among circulating picornaviruses
Caroline Tapparel, Thomas Junier, Daniel Gerlach, et al.
Oncogene
|
March 2, 2018
The novel BET bromodomain inhibitor BI 894999 represses super-enhancer-associated transcription and synergizes with CDK9 inhibition in AML
Daniel Gerlach, Ulrike Tontsch-Grunt, Anke Baum, et al.
Biorxiv : the Preprint Server for Biology
|
December 18, 2023
SOS1 inhibition enhances the efficacy of and delays resistance to G12C inhibitors in lung adenocarcinoma
Brianna R Daley, Nancy E Sealover, Erin Sheffels, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 23, 2021
COVID-19 Outbreak Associated With a Fitness Center-Minnesota, September-November 2020
Tara Suhs, Daniel Gerlach, Jacob Garfin, et al.
Plos One
|
November 19, 2011
Astrovirus infection in hospitalized infants with severe combined immunodeficiency after allogeneic hematopoietic stem cell transplantation
Werner Wunderli, Astrid Meerbach, Tayfun Güngör, et al.
Oncogenesis
|
February 24, 2018
Efficacy of the highly selective focal adhesion kinase inhibitor BI 853520 in adenocarcinoma xenograft models is linked to a mesenchymal tumor phenotype
Ulrich A Hirt, Irene C Waizenegger, Norbert Schweifer, et al.
Molecular Cancer Therapeutics
|
December 23, 2024
Pan-KRAS Inhibitors BI-2493 and BI-2865 Display Potent Antitumor Activity in Tumors with KRAS Wild-type Allele Amplification
Antonio Tedeschi, Fiorella Schischlik, Francesca Rocchetti, et al.
Molecular Cancer Therapeutics
|
September 11, 2024
Discovery and Characterization of Brigimadlin, a Novel and Highly Potent MDM2-p53 Antagonist Suitable for Intermittent Dose Schedules
Andreas Gollner, Dorothea Rudolph, Ulrike Weyer-Czernilofsky, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 44) with videos related to
Sort By:
Page
of 5
Plos Genetics
|
November 21, 2015
Conserved piRNA Expression from a Distinct Set of piRNA Cluster Loci in Eutherian Mammals
Gung-Wei Chirn, Reazur Rahman, Yuliya A Sytnikova, et al.
Genes & Development
|
June 3, 2009
Integration of microRNA miR-122 in hepatic circadian gene expression
David Gatfield, Gwendal Le Martelot, Charles E Vejnar, et al.
Emerging Infectious Diseases
|
May 1, 2009
New respiratory enterovirus and recombinant rhinoviruses among circulating picornaviruses
Caroline Tapparel, Thomas Junier, Daniel Gerlach, et al.
Oncogene
|
March 2, 2018
The novel BET bromodomain inhibitor BI 894999 represses super-enhancer-associated transcription and synergizes with CDK9 inhibition in AML
Daniel Gerlach, Ulrike Tontsch-Grunt, Anke Baum, et al.
Biorxiv : the Preprint Server for Biology
|
December 18, 2023
SOS1 inhibition enhances the efficacy of and delays resistance to G12C inhibitors in lung adenocarcinoma
Brianna R Daley, Nancy E Sealover, Erin Sheffels, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 23, 2021
COVID-19 Outbreak Associated With a Fitness Center-Minnesota, September-November 2020
Tara Suhs, Daniel Gerlach, Jacob Garfin, et al.
Plos One
|
November 19, 2011
Astrovirus infection in hospitalized infants with severe combined immunodeficiency after allogeneic hematopoietic stem cell transplantation
Werner Wunderli, Astrid Meerbach, Tayfun Güngör, et al.
Oncogenesis
|
February 24, 2018
Efficacy of the highly selective focal adhesion kinase inhibitor BI 853520 in adenocarcinoma xenograft models is linked to a mesenchymal tumor phenotype
Ulrich A Hirt, Irene C Waizenegger, Norbert Schweifer, et al.
Molecular Cancer Therapeutics
|
December 23, 2024
Pan-KRAS Inhibitors BI-2493 and BI-2865 Display Potent Antitumor Activity in Tumors with KRAS Wild-type Allele Amplification
Antonio Tedeschi, Fiorella Schischlik, Francesca Rocchetti, et al.
Molecular Cancer Therapeutics
|
September 11, 2024
Discovery and Characterization of Brigimadlin, a Novel and Highly Potent MDM2-p53 Antagonist Suitable for Intermittent Dose Schedules
Andreas Gollner, Dorothea Rudolph, Ulrike Weyer-Czernilofsky, et al.
Page
of 5